Evidence map›Paper›PMID 31119063›Full record

ArticlePeerJ2019

The vaccina

Domenica Matranga, Cristina Lumia, Rossella Guarneri, Vincenza Maria Arculeo, Marcello Noto, Alessia Pivetti, Gregorio Serra, Maria Francesca Guarneri, Antonio Spera

Abstract read
In one paragraph

Article in PeerJ, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Domenica MatrangaDepartment of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, Palermo, Sicily, Italia.
Cristina LumiaUnit of Gynecology and Obstetrics, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Palermo, Sicily, Italia.
Rossella GuarneriUnit of Gynecology and Obstetrics, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Palermo, Sicily, Italia.
Vincenza Maria ArculeoUnit of Gynecology and Obstetrics, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Palermo, Sicily, Italia.
Marcello NotoUnit of Gynecology and Obstetrics, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Palermo, Sicily, Italia.
Alessia PivettiUnit of Gynecology and Obstetrics, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Palermo, Sicily, Italia.
Gregorio SerraUnit of Gynecology and Obstetrics, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Palermo, Sicily, Italia.
Maria Francesca GuarneriUnit of Gynecology and Obstetrics, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Palermo, Sicily, Italia.
Antonio SperaUnit of Gynecology and Obstetrics, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Palermo, Sicily, Italia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to introduce the VaccinaTion & Hpv Knowledge (THinK) questionnaire to assess knowledge about human papillomavirus (HPV) and attitude to HPV-vaccination. Its reliability and validity was demonstrated in a sample of women living in Sicily (southern Italy).

methodsA cross-sectional survey was conducted on a sample of 220 women at the "Paolo Giaccone" University Hospital in Palermo (Sicily), aged 18-61. Data were analyzed through Cronbach's alpha and exploratory factor analysis, followed by a structural equation model with measurement component. The two-level data structure was explicitly considered.

resultsThree dimensions were found: "knowledge of HPV infection (kHPV), "Attitude to be vaccinated against HPV (aHPV)" and "Knowledge about vaccines (KV)" (97% overall explained variance). Internal consistency was good for the whole questionnaire (0.82) and the first dimension (0.88) and acceptable for the second (0.78) and the third dimension (0.73). 23% of women showed no or little knowledge of HPV and 44.3% of women had no or little knowledge about HPV induced lesions. DISCUSSION: The use of a validated questionnaire may serve as a useful measure to assess general knowledge about HPV and attitude towards vaccination against HPV in the primary prevention setting.

Indexed as

AttitudeKnowledgeMultilevel structural equation modelPapillomavirusQuestionnaireReliabilityVaccinationValidity

Identifiers

PMID31119063
PMCPMC6511389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.